EU Experience: CE-Marked Diagnostic AI Article #8 in Medical ML for Ukrainian Doctors Series EU CE-marked diagnostic AI experience and standards By Oleh Ivchenko | Researcher, ONPU | Stabilarity Hub | February 8, 2026 š Key Questions Addressed How does the European regulatory framework for medical AI differ from the US FDA approach? What is…
Article #7 in Medical ML for Ukrainian Doctors Series FDA-approved AI devices and clinical evidence By Oleh Ivchenko | Researcher, ONPU | Stabilarity Hub | February 8, 2026 š Key Questions Addressed How has the US regulatory landscape shaped AI medical device development, and what does the current FDA approval landscape look like? What evidence…
š Academic Citation: Ivchenko, O. (2026). Regulatory Landscape for Medical AI: FDA, CE Marking, and Ukrainian MHSU. Medical ML Diagnosis Series. Odesa National Polytechnic University. Article #6 in Medical ML for Ukrainian Doctors Series By Oleh Ivchenko | Researcher, ONPU | Stabilarity Hub | February 8, 2026 š Key Questions Addressed How do FDA, EU,…